Low invasive angiogenic therapy for myocardial infarction by retrograde transplantation of mononuclear cells expressing the VEGF gene

International Journal of Cardiology

Volumn 142, Issue 1, 2010, Pages 56-64

  Hagikura, Kazuhiro ^a   Fukuda, Noboru ^a,b   Yokoyama, Shin ichiro ^a   Yuxin, Li ^a   Kusumi, Yoshiaki ^a   Matsumoto, Taro ^a   Ikeda, Yukihiro ^b   Kunimoto, Satoshi ^a   Takayama, Tadateru ^a   Jumabay, Medet ^a   Mitsumata, Masako ^a   Saito, Satoshi ^a   Hirayama, Atsushi ^a   Mugishima, Hideo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Coronary vein; Myocardial infarction; VEGF

Indexed keywords

VASCULOTROPIN 165;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD; CAPILLARY DENSITY; CELL ISOLATION; CELL TRANSPLANTATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY VEIN; GENE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HEART; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HISTOLOGY; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; THERAPY EFFECT;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SUS SCROFA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77953236508     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.108     Document Type: Article

References (43)

1. Herzog E.L., Chai L., and Krause D.S. Plasticity of marrow-derived stem cells. Blood 102 (2003) 3483-3493
2. Asahara T., Murohara T., and Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
3. Asahara T., Masuda H., and Takahashi T. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
4. Tateishi-Yuyama E., Matsubara H., and Murohara T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360 (2002) 427-435
5. Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., and Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann NY Acad Sci 938 (2001) 221-229
6. Orlic D., Kajstura J., and Chimenti S. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
7. Assmus B., Schachinger V., and Teupe C. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
8. Schachinger V., Assmus B., and Britten M.B. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 44 (2004) 1690-1699
9. Wollert K.C., Meyer G.P., and Lotz J. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
10. Schachinger V., Erbs S., and Elsasser A. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27 (2006) 2775-2783
11. Symes J.F., Losordo D.W., Vale P.R., et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68 (1999) 830-836
12. Grines C.L., Watkins M.W., and Helmer G. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation 105 (2002) 1291-1297
13. Losordo D.W., Vale P.R., and Hendel R.C. Phase 1/2 placebo-controlled, double-blind, dose escalating trial of myocardial vascular endothelial growth factor2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105 (2002) 2012-2018
14. Vale P.R., Losordo D.W., and Milliken C.E. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103 (2001) 2138-2143
15. Iwaguro H., Yamaguchi J., and Kalka C. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105 (2002) 732-738
16. Ikeda Y., Fukuda N., and Wada M. Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene. Hypertens Res 27 (2004) 119-128
17. Suzuki K., Murtuza B., and Smolenski R.T. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104 suppl (2001) I207-I212
18. Yau T.M., Fung K., Weisel R.D., Fujii T., Mickle D.A., and Li R.K. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104 suppl (2001) I218-I222
19. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
20. Tse H.F., Kwong Y.L., Chan J.K., Lo G., Ho C.L., and Lau C.P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361 (2003) 47-49
21. Fuchs S., Satler L.F., and Kornowski R. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 41 (2003) 1721-1724
22. Yokoyama S., Fukuda N., and Li Y. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease. J Mol Cell Cardiol 40 (2006) 24-34
23. Tomita S., Mickle D.A., Weisel R.D., et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123 (2002) 1132-1140
24. Kawamoto A., Murayama T., and Kusano K. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 110 (2004) 1398-1405
25. Britten M.B., Abolmaali N.D., and Assmus B. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108 (2003) 2212-2218
26. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
27. Henry T.D., Annex B.H., and McKendall G.R. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107 (2003) 1359-1365
28. Losordo D.W., Vale P.R., Symes J.F., et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98 (1998) 2800-2804
29. Rosengart T.K., Lee L.Y., and Patel S.R. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100 (1999) 468-474
30. Vale P.R., Losordo D.W., Milliken C.E., et al. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 102 (2000) 965-974
31. Kamihata H., Matsubara H., and Nishiue T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
32. Rutanen J., Rissanen T.T., and Markkanen J.E. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 109 (2004) 1029-1035
33. von Degenfeld G., Raake P., and Kupatt C. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J Am Coll Cardiol 42 (2003) 1120-1128
34. Thompson C.A., Nasseri B.A., Makower J., et al. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 41 (2003) 1964-1971
35. Orlic D. Stem cell repair in ischemic heart disease: an experimental model. Int J Hematol 76 (2002) 144-145
36. Terada N., Hamazaki T., Oka M., et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416 (2002) 542-545
37. Ye L., Haider H.K.h., Tan R., et al. Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation 116 (2007) I113-I120
38. Young P.P., Hofling A.A., and Sands M.S. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc Natl Acad Sci USA 99 (2002) 11951-11956
39. Vandervelde S., van Luyn M.J., Tio R.A., and Harmsen M.C. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 39 (2005) 363-376
40. Tatsumi T., Ashihara E., and Yasui T. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J 71 (2007) 1199-1207
41. Luo Z., Diaco M., Murohara T., Ferrara N., Isner J.M., and Symes J.F. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 64 (1997) 993-998
42. Tateno K., Minamino T., and Toko H. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 98 (2006) 1194-1202
43. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150